Van Waes L, Segers J, Van Egmond J, Van Nimmen L, Barbier F, Wieme R, Demeulenaere L
Br Med J. 1974 Aug 17;3(5928):444-6. doi: 10.1136/bmj.3.5928.444.
A long-term follow-up of 45 patients with chronic hepatitis and 41 with cirrhosis is reported. Hepatitis-B antigen (HBAg) was present in 19 (42%) of the chronic hepatitis patients and in 20 (49%) of those with cirrhosis. The clinical course and biochemical and histological findings in the HBAg-positive and the HBAg-negative cases were similar, suggesting that HBAg-positive chronic liver disease is not a distinct clinical entity. The presence of antigen and autoantibodies was not found to be mutually exclusive. In HBAg-positive cases antigen tended to persist for months and years. When no irreversible lesions exist disappearance of the antigen may be a sign that the liver disease will resolve.
报告了对45例慢性肝炎患者和41例肝硬化患者的长期随访情况。19例(42%)慢性肝炎患者和20例(49%)肝硬化患者存在乙型肝炎抗原(HBAg)。HBAg阳性和HBAg阴性病例的临床病程以及生化和组织学检查结果相似,这表明HBAg阳性慢性肝病并非一种独特的临床实体。未发现抗原和自身抗体的存在相互排斥。在HBAg阳性病例中,抗原往往会持续数月甚至数年。当不存在不可逆病变时,抗原消失可能是肝病将痊愈的迹象。